AstraZeneca Vaccine Shows Promising Results
Just recently, AstraZeneca, a pharmaceutical company testing a coronavirus (COVID-19) vaccine, announced that its vaccine has shown some promising results. Its ongoing clinical trials suggest that the vaccine provided an immune response in both older and younger adults.
The scientists also claimed that the adverse side effects from the vaccine were significantly lesser than expected. Thus, the AstraZeneca scientists claim that the potential vaccine could be widely distributed among the most vulnerable population.
The scientists at Oxford University in the UK are working closely with AstraZeneca.
Despite the drug being in the process of being tested, AstraZeneca expressed its confidence that it will provide effective protection against COVID-19. Moreover, the company said that it started production and could provide three billion doses on hand by the time the vaccine wins approval.
“It is encouraging to see immunogenicity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the COVID-19 disease severity is higher,” said an AstraZeneca spokesman.
Editor’s note on AstraZeneca Vaccine Produced Immune Response in Both Young and Old People:
This piece is to inform you about AstraZeneca Vaccine Produced Immune Response in Both Young and Old.
For further information about the recent COVID updates, don’t hesitate to send us an email at Outreach@ConsiderTheConsumer.com, find us on Twitter or Facebook, or even connect with us directly on our website! We look forward to hearing from you all.
Similarly, please check out our current list of Class Actions and Class Action Investigations, here.
Interested in articles like these? Become a subscriber below!